SCIENTIFIC ADVISORY BOARD
Mariano A. Garcia-Blanco, MD, PhD – SAB Chair
RNA Biology and Immunology
-
Chair & Professor, Microbiology, Immunology & Cancer Biology, University of Virginia
-
Founder of five companies: Intronn (later VIRxSYS), Veri-Q, SABio, ABS, and Emervax
-
Member of American Academy of Arts and Sciences (2022) with over 190 peer-reviewed publications
Edward J. Benz, Jr., MD
Oncology and RNA splicing
-
Emeritus President & CEO, Dana-Farber Cancer Institute (led the institute from 2000-2016)
-
Richard & Susan Smith Distinguished Professor of Medicine, Harvard Medical School
-
Member, Institute of Medicine (2004), American Academy of Arts and Sciences (2004), and others
George J. Hutton, MD
Principal investigator in > 40 MS trials
-
Professor and Vice Chair for Clinical Affairs, Neurology, Baylor College of Medicine
-
Medical Director, Maxine Mesinger Multiple Sclerosis Clinic
-
Practicing clinician who treats dozens of MS patients weekly and have extensive clinical trial experience
Adrian R. Krainer, PhD
Therapeutic ASOs (academic developer of ASO drug Spinraza®)
-
St. Giles Professor & Cancer Center Research Deputy Director, Cold Spring Harbor Laboratory
-
Co-founder & Director, Stoke Therapeutics
-
2019 Breakthrough Prize, Life Sciences; 2021 Wolf Prize, Medicine; 2022 Watanabe Prize, Translational Research
Sir Richard Roberts, PhD
Nobel Prize Laureate for discoveries on RNA splicing
-
Chief Scientific Officer, New England Biolabs
-
Visionary scientist proficient in scientific product innovation
-
1993 Nobel Prize in Medicine; 2007 Gabor Medal; 2023 National Academy of Sciences
Bobby W. Sandage, Jr., PhD
Senior Advisor, Drug Development & Regulatory
-
CEO & President, Euclises Pharmaceuticals; Managing Director or Partner of two Venture Funds
-
Senior life science executive, serial entrepreneur, and venture capital investor (>35 years)
-
Significant Regulatory Experience: >14 approved drugs